NPI: 1780658443 · YPSILANTI, MI 48197 · Maternal & Fetal Medicine Physician · NPI assigned 02/17/2006
Authorized official GUSHO, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | GUSHO, MICHAEL (CFO SE MI REGION) |
| NPI Enumeration Date | 02/17/2006 |
Other providers sharing the same authorized official: GUSHO, MICHAEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 190,393 | $7.02M |
| 2019 | 276,222 | $7.25M |
| 2020 | 269,878 | $7.84M |
| 2021 | 365,861 | $11.20M |
| 2022 | 382,455 | $10.99M |
| 2023 | 413,412 | $11.47M |
| 2024 | 329,469 | $9.45M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 29,151 | 26,901 | $12.91M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 38,491 | 35,989 | $9.36M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 45,857 | 42,855 | $5.95M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 55,268 | 46,830 | $4.16M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 35,867 | 32,180 | $3.37M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 20,293 | 19,394 | $1.43M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23,565 | 22,611 | $1.36M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10,370 | 10,116 | $1.32M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 24,257 | 21,684 | $881K |
| 96361 | Intravenous infusion, hydration; each additional hour | 24,989 | 21,095 | $827K |
| 71046 | Radiologic examination, chest; 2 views | 21,529 | 20,675 | $818K |
| 80061 | Lipid panel | 38,502 | 38,325 | $796K |
| 70450 | Computed tomography, head or brain; without contrast material | 7,787 | 7,417 | $739K |
| 96375 | Therapeutic injection; each additional sequential IV push | 27,027 | 21,797 | $732K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 38,539 | 37,663 | $719K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 37,854 | 37,030 | $700K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 31,971 | 27,976 | $686K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6,880 | 6,431 | $684K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,242 | 3,231 | $621K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,056 | 6,667 | $554K |
| G0378 | Hospital observation service, per hour | 11,598 | 10,300 | $512K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,341 | 2,320 | $491K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,994 | 1,771 | $473K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,219 | 1,212 | $411K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5,569 | 5,451 | $396K |
| 84443 | Thyroid stimulating hormone (TSH) | 49,153 | 47,960 | $390K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,001 | 988 | $378K |
| 93975 | 3,203 | 3,112 | $372K | |
| 80053 | Comprehensive metabolic panel | 91,686 | 83,407 | $342K |
| 59025 | Fetal non-stress test | 3,460 | 2,183 | $339K |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 9,948 | 9,933 | $312K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 13,837 | 12,836 | $311K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 17,180 | 17,107 | $294K |
| 71045 | Radiologic examination, chest; single view | 8,309 | 7,915 | $288K |
| 76830 | Ultrasound, transvaginal | 5,054 | 4,945 | $288K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,647 | 2,623 | $284K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 5,762 | 5,761 | $279K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,927 | 4,833 | $275K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 569 | 563 | $261K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,441 | 2,366 | $244K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 13,190 | 12,827 | $244K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 383 | 366 | $241K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,017 | 2,952 | $236K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12,223 | 11,787 | $229K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 10,842 | 10,835 | $228K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 12,583 | 12,537 | $202K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 259 | 259 | $199K |
| 41899 | Unlisted procedure, dentoalveolar structures | 596 | 594 | $192K |
| 88142 | 15,324 | 15,310 | $187K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 90,491 | 80,070 | $187K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 3,210 | 3,181 | $166K |
| 95811 | 341 | 338 | $166K | |
| 93970 | 1,560 | 1,527 | $165K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 27,747 | 27,610 | $151K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 266 | 265 | $132K |
| 82728 | 16,587 | 16,365 | $131K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 238 | 237 | $129K |
| 76770 | 2,107 | 2,081 | $121K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 39,925 | 34,168 | $120K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,117 | 4,837 | $118K |
| 82607 | 13,764 | 13,697 | $117K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,690 | 2,589 | $115K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 934 | 921 | $114K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,137 | 1,128 | $114K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 29,887 | 28,242 | $113K |
| 93971 | 2,187 | 2,139 | $112K | |
| 85027 | 49,476 | 44,039 | $109K | |
| 70496 | 911 | 902 | $106K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,549 | 3,740 | $105K |
| 62323 | 339 | 337 | $103K | |
| 86780 | 11,933 | 11,779 | $97K | |
| 77066 | Tomosynthesis, mammo | 1,678 | 1,670 | $93K |
| 76642 | 2,413 | 2,398 | $93K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4,490 | 4,449 | $92K |
| 87081 | 25,732 | 25,370 | $89K | |
| 86900 | 11,309 | 10,340 | $87K | |
| 86480 | 2,406 | 2,390 | $84K | |
| 84466 | 11,218 | 11,106 | $83K | |
| 82947 | 2,230 | 2,143 | $76K | |
| 70491 | 690 | 676 | $76K | |
| 97161 | 769 | 762 | $70K | |
| 84439 | 18,049 | 17,699 | $69K | |
| 10060 | 748 | 726 | $67K | |
| 93017 | 1,738 | 1,717 | $67K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,120 | 1,117 | $66K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,083 | 1,081 | $66K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6,338 | 6,193 | $63K |
| J1750 | Injection, iron dextran, 50 mg | 644 | 387 | $61K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,087 | 1,283 | $60K |
| 87808 | 10,865 | 10,714 | $58K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 16,229 | 12,063 | $57K |
| 72100 | 2,441 | 2,424 | $57K | |
| 74183 | 384 | 382 | $54K | |
| 87340 | 10,506 | 10,438 | $54K | |
| 36415 | Collection of venous blood by venipuncture | 104,315 | 94,796 | $53K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 296 | 204 | $53K |
| 95806 | 658 | 658 | $53K | |
| 97162 | 339 | 330 | $52K | |
| 71250 | 1,023 | 1,009 | $50K | |
| 84702 | 17,515 | 15,137 | $49K | |
| 77065 | Tomosynthesis, mammo | 1,146 | 1,106 | $49K |
| 87077 | 10,355 | 10,114 | $49K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5,888 | 5,846 | $49K |
| 76536 | 887 | 884 | $48K | |
| 83540 | 12,567 | 12,382 | $47K | |
| 87529 | 1,654 | 1,296 | $47K | |
| 73564 | 1,103 | 1,100 | $45K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 38,340 | 30,828 | $45K |
| 47562 | 12 | 12 | $44K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1,122 | 1,065 | $43K |
| 86850 | 11,949 | 11,176 | $43K | |
| 72141 | 325 | 324 | $42K | |
| 74018 | 2,088 | 1,946 | $41K | |
| 77386 | 138 | 12 | $40K | |
| 73630 | 3,727 | 3,662 | $40K | |
| 73610 | 3,404 | 3,274 | $39K | |
| 70486 | 1,170 | 1,159 | $38K | |
| 86235 | 657 | 645 | $37K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 2,883 | 2,883 | $36K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,076 | 731 | $35K |
| 87186 | 8,184 | 7,967 | $35K | |
| 82746 | 4,223 | 4,197 | $34K | |
| 80074 | 1,566 | 1,550 | $34K | |
| 90686 | 2,044 | 2,038 | $32K | |
| 83970 | 1,359 | 1,338 | $32K | |
| 84403 | 2,352 | 2,311 | $31K | |
| 84481 | 3,343 | 3,294 | $31K | |
| 73130 | 3,380 | 3,302 | $30K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,294 | 639 | $29K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 2,566 | 2,557 | $29K |
| 96367 | 1,022 | 804 | $28K | |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 373 | 150 | $28K |
| 43235 | 70 | 69 | $27K | |
| 87147 | 8,774 | 7,479 | $27K | |
| 87070 | 6,411 | 6,243 | $26K | |
| 97165 | 352 | 347 | $25K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,457 | 608 | $25K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 390 | 306 | $25K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 373 | 373 | $25K |
| 83880 | 4,343 | 4,124 | $24K | |
| 82670 | 1,378 | 1,360 | $24K | |
| 73030 | 2,893 | 2,753 | $24K | |
| 82043 | 7,277 | 7,212 | $24K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,137 | 3,003 | $24K |
| 86762 | 3,860 | 3,845 | $23K | |
| 83655 | 3,220 | 3,211 | $23K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 1,994 | 1,984 | $23K |
| 73110 | 2,206 | 2,138 | $23K | |
| 71271 | 389 | 389 | $23K | |
| 83735 | 31,192 | 25,028 | $23K | |
| Q3014 | Telehealth originating site facility fee | 1,464 | 1,411 | $22K |
| 81001 | 41,198 | 38,463 | $22K | |
| 93458 | 14 | 14 | $22K | |
| 83001 | 1,813 | 1,806 | $21K | |
| 93296 | 1,146 | 1,145 | $20K | |
| 88307 | 253 | 252 | $20K | |
| 88342 | 572 | 559 | $20K | |
| 87536 | 410 | 409 | $20K | |
| 82570 | 7,214 | 6,752 | $19K | |
| 86803 | 2,781 | 2,766 | $19K | |
| 84146 | 1,686 | 1,677 | $19K | |
| 86140 | 9,006 | 8,513 | $18K | |
| 86769 | 916 | 906 | $18K | |
| 87088 | 4,629 | 4,429 | $18K | |
| 82784 | 2,337 | 2,304 | $18K | |
| 19083 | 24 | 24 | $17K | |
| 86364 | 1,290 | 1,181 | $17K | |
| 87205 | 9,134 | 8,919 | $17K | |
| 83516 | 1,239 | 879 | $16K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,698 | 3,486 | $16K |
| 85610 | 13,164 | 10,381 | $15K | |
| 86258 | 955 | 950 | $15K | |
| 80076 | 7,064 | 6,737 | $15K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 1,200 | 1,196 | $15K |
| 88304 | 1,620 | 1,598 | $15K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 38 | 37 | $14K |
| 96415 | 311 | 253 | $14K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 1,513 | 1,436 | $14K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 14 | 13 | $13K |
| 73502 | 1,368 | 1,330 | $13K | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | 315 | 314 | $13K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 185 | 185 | $13K |
| 82950 | 4,616 | 4,598 | $13K | |
| 64483 | 26 | 26 | $13K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,037 | 2,007 | $12K |
| 72050 | 246 | 246 | $12K | |
| 88312 | 398 | 391 | $12K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2,617 | 2,428 | $12K |
| 86039 | 2,010 | 1,992 | $12K | |
| 72197 | 53 | 53 | $12K | |
| 73562 | 2,504 | 2,445 | $11K | |
| 73140 | 797 | 783 | $11K | |
| 86706 | 1,887 | 1,871 | $10K | |
| 85652 | 9,060 | 8,666 | $10K | |
| 86787 | 1,558 | 1,553 | $10K | |
| 80055 | 296 | 296 | $10K | |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 244 | 101 | $10K |
| 86200 | 1,242 | 1,242 | $10K | |
| 83721 | 1,449 | 1,438 | $10K | |
| 87522 | Neg quan hep c or qual rna | 445 | 410 | $9K |
| 70498 | 982 | 971 | $9K | |
| 74174 | 92 | 90 | $9K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 610 | 603 | $9K |
| 83690 | 19,609 | 18,041 | $9K | |
| 86901 | 12,247 | 11,248 | $9K | |
| 83002 | 736 | 734 | $9K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 98 | 97 | $8K |
| 86225 | 981 | 969 | $8K | |
| 73080 | 936 | 919 | $8K | |
| 93351 | 27 | 27 | $8K | |
| 96127 | 1,562 | 1,490 | $8K | |
| 87102 | 1,351 | 1,331 | $8K | |
| 86038 | 969 | 963 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,486 | 4,288 | $7K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 49 | 32 | $7K |
| 88341 | 124 | 121 | $7K | |
| 86431 | 2,119 | 2,113 | $7K | |
| 76870 | 332 | 315 | $7K | |
| 82565 | 3,918 | 3,714 | $7K | |
| 97597 | 84 | 54 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,295 | 12,794 | $7K |
| 87106 | 963 | 907 | $7K | |
| 82248 | 3,354 | 3,044 | $7K | |
| 80069 | 1,441 | 1,368 | $6K | |
| 84484 | 20,386 | 16,023 | $6K | |
| 93225 | 125 | 125 | $6K | |
| 73221 | 51 | 51 | $6K | |
| 87634 | 140 | 139 | $6K | |
| 87899 | 411 | 402 | $6K | |
| 84460 | 3,097 | 3,030 | $6K | |
| 96417 | 147 | 106 | $6K | |
| 86160 | 419 | 414 | $6K | |
| 76882 | 151 | 139 | $6K | |
| 86696 | 533 | 529 | $6K | |
| 0002A | 226 | 225 | $6K | |
| 88112 | 365 | 356 | $6K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 295 | 295 | $6K |
| 84703 | 12,199 | 11,654 | $6K | |
| 82550 | 3,257 | 2,999 | $6K | |
| 86592 | 2,043 | 2,033 | $6K | |
| 84450 | 2,370 | 2,294 | $6K | |
| 85730 | 6,667 | 6,311 | $6K | |
| 90834 | Psychotherapy, 45 minutes with patient | 148 | 85 | $5K |
| 97116 | 731 | 473 | $5K | |
| 84550 | 2,584 | 2,426 | $5K | |
| 86704 | 928 | 924 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,076 | 1,865 | $5K |
| 86376 | 527 | 524 | $5K | |
| 81025 | 1,308 | 1,277 | $5K | |
| 84156 | 3,663 | 3,152 | $5K | |
| 84153 | 450 | 438 | $5K | |
| 93922 | 145 | 144 | $4K | |
| 93298 | 223 | 221 | $4K | |
| 86695 | 535 | 530 | $4K | |
| 73590 | 1,049 | 1,026 | $4K | |
| 84100 | 7,606 | 6,198 | $4K | |
| 77336 | 56 | 27 | $4K | |
| 76801 | 78 | 75 | $4K | |
| 83020 | 647 | 646 | $4K | |
| 0001A | 236 | 236 | $4K | |
| 72072 | 197 | 196 | $4K | |
| G0422 | Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 61 | 13 | $4K |
| 85007 | 3,941 | 3,593 | $3K | |
| 83615 | 1,488 | 1,355 | $3K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 18 | 18 | $3K |
| 85379 | 7,032 | 6,847 | $3K | |
| 73090 | 830 | 803 | $3K | |
| 84165 | 494 | 476 | $3K | |
| 82247 | 1,544 | 1,330 | $3K | |
| 86870 | 38 | 27 | $3K | |
| 72146 | 14 | 14 | $3K | |
| 82533 | 261 | 248 | $3K | |
| 82150 | 821 | 793 | $3K | |
| 85018 | 2,056 | 1,963 | $3K | |
| 87338 | 310 | 310 | $3K | |
| 82951 | 296 | 296 | $3K | |
| 85045 | 1,259 | 1,181 | $2K | |
| 72170 | 296 | 288 | $2K | |
| 84630 | 312 | 312 | $2K | |
| 87046 | 499 | 496 | $2K | |
| 86665 | 119 | 119 | $2K | |
| 73700 | 52 | 52 | $2K | |
| 97166 | 53 | 52 | $2K | |
| 90656 | 115 | 115 | $2K | |
| 86765 | 510 | 510 | $2K | |
| 0012A | 59 | 59 | $2K | |
| 0011A | 82 | 82 | $2K | |
| 87045 | 504 | 501 | $2K | |
| 86360 | 92 | 92 | $2K | |
| 82525 | 264 | 261 | $2K | |
| 86694 | 267 | 264 | $2K | |
| 93271 | 38 | 38 | $2K | |
| 72158 | 25 | 24 | $2K | |
| 71101 | 106 | 105 | $2K | |
| 82040 | 1,516 | 1,486 | $2K | |
| 86735 | 424 | 422 | $2K | |
| 91320 | 16 | 16 | $2K | |
| 81003 | 4,916 | 4,830 | $2K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 211 | 206 | $2K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 3,540 | 3,466 | $2K |
| 77080 | 25 | 25 | $2K | |
| J1453 | Injection, fosaprepitant, 1 mg | 38 | 26 | $1K |
| 82627 | 93 | 93 | $1K | |
| 36430 | 16 | 14 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 654 | 644 | $1K |
| 86800 | 136 | 135 | $1K | |
| 82465 | 610 | 605 | $1K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 35 | 16 | $1K |
| 96376 | 11,955 | 7,409 | $1K | |
| 82805 | 3,914 | 3,457 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,658 | 2,622 | $1K |
| 86141 | 283 | 276 | $1K | |
| 83013 | 53 | 53 | $1K | |
| 76886 | 25 | 25 | $1K | |
| 74019 | 82 | 81 | $1K | |
| 0031A | 41 | 41 | $1K | |
| G0008 | Administration of influenza virus vaccine | 198 | 194 | $1K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 17 | 14 | $1K |
| 86003 | 23 | 12 | $1K | |
| 85014 | 954 | 938 | $1K | |
| 80178 | 439 | 400 | $1K | |
| 87040 | 2,065 | 1,486 | $985.71 | |
| 84207 | 51 | 51 | $980.70 | |
| 84520 | 1,289 | 1,178 | $906.84 | |
| 84425 | 69 | 69 | $903.47 | |
| 80164 | 257 | 241 | $900.01 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 91 | 91 | $893.85 |
| 86308 | 658 | 652 | $878.58 | |
| 86664 | 104 | 104 | $869.05 | |
| 87593 | 13 | 12 | $867.48 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 39 | 13 | $863.84 |
| 82310 | 947 | 926 | $862.63 | |
| 82330 | 147 | 130 | $858.08 | |
| 0124A | 35 | 35 | $825.97 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 12 | 12 | $817.97 |
| 29515 | 13 | 12 | $758.23 | |
| 86663 | 105 | 105 | $755.00 | |
| 83993 | 57 | 57 | $738.78 | |
| 76881 | 12 | 12 | $722.30 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 13 | 13 | $717.96 |
| 86147 | 27 | 26 | $714.58 | |
| 83498 | 36 | 36 | $683.60 | |
| 87493 | 45 | 45 | $682.39 | |
| 86593 | 237 | 234 | $682.29 | |
| 90480 | 16 | 16 | $574.58 | |
| 83718 | 149 | 148 | $562.25 | |
| 82105 | 81 | 77 | $553.63 | |
| 84155 | 916 | 893 | $548.80 | |
| 73060 | 156 | 147 | $537.35 | |
| 84145 | 466 | 457 | $524.71 | |
| 84132 | 915 | 777 | $519.77 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 90 | 67 | $517.07 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 28 | 28 | $501.11 |
| 82952 | 199 | 199 | $487.51 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 78 | 78 | $486.00 |
| 82274 | 60 | 60 | $479.89 | |
| 83605 | 7,810 | 6,793 | $475.15 | |
| 73552 | 129 | 122 | $463.60 | |
| 86708 | 64 | 64 | $452.47 | |
| 85651 | 330 | 300 | $450.66 | |
| 83520 | 1,974 | 1,731 | $444.20 | |
| 87209 | 193 | 189 | $441.47 | |
| 87498 | 16 | 16 | $380.04 | |
| 82652 | 24 | 24 | $376.75 | |
| 84075 | 766 | 750 | $350.72 | |
| 81002 | 208 | 195 | $350.69 | |
| 87177 | 192 | 189 | $337.28 | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34 | 29 | $333.92 |
| 82044 | 121 | 121 | $331.09 | |
| 83521 | 13 | 13 | $326.42 | |
| 87210 | 1,066 | 845 | $314.67 | |
| 84255 | 15 | 15 | $284.48 | |
| 97535 | Self-care/home management training, each 15 minutes | 71 | 64 | $272.92 |
| 82803 | 183 | 179 | $267.54 | |
| 84144 | 16 | 15 | $228.58 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,184 | 1,063 | $211.70 |
| 73560 | 14 | 14 | $195.44 | |
| 87015 | 54 | 54 | $193.68 | |
| 12001 | 519 | 516 | $193.04 | |
| 87324 | 42 | 42 | $191.01 | |
| 97802 | 58 | 58 | $182.56 | |
| 87449 | 45 | 45 | $180.34 | |
| 97022 | 34 | 16 | $179.64 | |
| 84295 | 720 | 698 | $168.60 | |
| 82140 | 40 | 39 | $159.87 | |
| 82374 | 712 | 695 | $155.19 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 113 | 112 | $150.73 |
| 86304 | 15 | 13 | $132.43 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 2,413 | 1,928 | $129.05 |
| 82378 | 12 | 12 | $125.79 | |
| 86255 | 18 | 13 | $123.72 | |
| 86618 | 13 | 13 | $120.70 | |
| 97803 | 14 | 13 | $120.00 | |
| 74022 | 79 | 79 | $116.52 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 26,233 | 22,507 | $116.29 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 803 | 664 | $114.28 |
| 84590 | 13 | 13 | $112.45 | |
| 82435 | 651 | 639 | $97.00 | |
| 83986 | 736 | 681 | $71.12 | |
| 90715 | 3,264 | 3,237 | $69.53 | |
| 29125 | 191 | 186 | $67.94 | |
| 97804 | 31 | 14 | $64.00 | |
| 83014 | 42 | 42 | $63.57 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 18,876 | 16,589 | $47.84 |
| 83550 | 17 | 17 | $46.36 | |
| 82010 | 248 | 228 | $42.76 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 24,133 | 20,442 | $41.75 |
| 86703 | 53 | 53 | $36.17 | |
| 87075 | 16 | 13 | $34.14 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 4,785 | 2,269 | $33.47 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 9,055 | 7,146 | $26.65 |
| J3490 | Unclassified drugs | 3,549 | 2,685 | $19.57 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 13,217 | 10,766 | $19.23 |
| J2060 | Injection, lorazepam, 2 mg | 3,402 | 2,619 | $13.30 |
| J1836 | Injection, metronidazole, 10 mg | 226 | 161 | $12.94 |
| J2704 | Injection, propofol, 10 mg | 11,522 | 10,806 | $12.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 11,081 | 10,623 | $11.15 |
| J1630 | Injection, haloperidol, up to 5 mg | 2,478 | 2,129 | $10.94 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 8,004 | 6,990 | $8.86 |
| 80051 | 26 | 25 | $7.90 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,393 | 1,938 | $7.88 |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,617 | 6,407 | $7.50 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 11,655 | 10,951 | $7.08 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 4,665 | 4,035 | $6.46 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,471 | 5,442 | $5.07 |
| 82009 | 28 | 25 | $2.97 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 499 | 456 | $1.54 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,515 | 997 | $1.50 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,652 | 3,247 | $1.00 |
| A9270 | Non-covered item or service | 1,957 | 995 | $0.03 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,175 | 1,239 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 60 | 59 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,659 | 1,154 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,273 | 3,754 | $0.00 |
| 96368 | 286 | 237 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 6,436 | 4,466 | $0.00 |
| C1769 | Guide wire | 1,171 | 1,126 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 1,370 | 516 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,072 | 1,028 | $0.00 |
| 94760 | 117 | 64 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 692 | 468 | $0.00 |
| 36416 | 181 | 178 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 415 | 407 | $0.00 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 552 | 340 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 592 | 584 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 374 | 373 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 488 | 485 | $0.00 |
| 12002 | 63 | 63 | $0.00 | |
| 99156 | 147 | 140 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 384 | 261 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 78 | 77 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 79 | 78 | $0.00 |
| 0352U | 155 | 154 | $0.00 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 92 | 88 | $0.00 |
| 80320 | 32 | 29 | $0.00 | |
| 87807 | 14 | 14 | $0.00 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 13 | 12 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 65 | 29 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 90 | 70 | $0.00 |
| C1781 | Mesh (implantable) | 13 | 12 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 101 | 98 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 44 | 12 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 46 | 38 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 17 | 14 | $0.00 |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 13 | 12 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 31 | 22 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 30 | 30 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 24 | 23 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 3,299 | 2,195 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 4,566 | 4,099 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 280 | 263 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,452 | 2,882 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 257 | 257 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 800 | 786 | $0.00 |
| 76937 | 449 | 351 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 457 | 449 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 740 | 737 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,249 | 1,065 | $0.00 |
| 12011 | 123 | 122 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 243 | 186 | $0.00 |
| 99152 | 127 | 124 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 177 | 177 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,058 | 1,030 | $0.00 |
| C1752 | Catheter, hemodialysis/peritoneal, short-term | 173 | 171 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 140 | 71 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 183 | 160 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 502 | 498 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 177 | 62 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 28 | 28 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 450 | 264 | $0.00 |
| 93226 | 85 | 85 | $0.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 15 | 12 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 69 | 69 | $0.00 |
| 93356 | 136 | 135 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 217 | 120 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | 12 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 12 | 12 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 89 | 64 | $0.00 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 24 | 24 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 12 | 12 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 60 | 52 | $0.00 |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg | 18 | 13 | $0.00 |
| C1758 | Catheter, ureteral | 13 | 13 | $0.00 |